Harvard Gastrointestinal, Liver, and Pancreatic Pathology 2025

Overview

Harvard Gastrointestinal, Liver, and Pancreatic Pathology 2025 is a comprehensive on-demand education resource that delivers in-depth insights into the latest advancements and diagnostic approaches in gastrointestinal, liver, and pancreatic pathology. Originally presented as a multi-day live meeting, it is now available for lifelong access, enabling pathologists and related specialists to enhance their expertise at their convenience.

On-demand Gastroenterology education — accessible anytime, anywhere.

Agenda

This program offers a detailed agenda covering a broad spectrum of pathology topics relevant to the gastrointestinal tract, liver, and pancreas, presented by expert faculty.

• Introduction/Welcome
• Barrett’s Esophagus and Associated Neoplasia — Mark Redston, MD
• Clinician’s Perspective- Upper GI Tract — Kunal Jajoo, MD
• Q&A
• Break
• Upper GI Inflammatory Conditions — Jonathan N. Glickman, MD, PhD
• Gastric Polyps and Precursor Lesions — Stuti Shroff, MBBS, PhD
• Celiac Disease and its Differential Diagnosis — Jeffrey Goldsmith, MD
• Slide Seminar on Upper GI Tract — Miranda Machacek, MD, PhD
• Q&A
• Lunch
• Biopsy Diagnosis of Colitis — Mark Redston, MD
• IBD: Controversies and Challenges — Michael G. Drage, MD, PhD
• Colon Polyps and Polyposis — Jonathan N. Glickman, MD, PhD
• Questions
• Break
• Challenges in Colon Cancer Pathology and Staging — Mark Redston, MD
• Surgical Pathology of Pancreatic Tumors — Mari Mino-Kenudson, MD
• Slide Seminar: Lower GI — Jonathan N. Glickman, MD, PhD
• Questions
• GISTs — Jason L. Hornick, MD, PhD
• Mesenchymal Tumors and Mesenchymal Polyps (other than GIST) — David Papke, MD, PhD
• GI Lymphomas — Judith A. Ferry, MD
• Questions
• Break
• Molecular Diagnostics in GI Tract Malignancies — Jonathan Nowak, MD, PhD
• Anal Pathology: Overview and Update — Jonathan N. Glickman, MD, PhD
• Appendiceal Tumors — Michael G. Drage, MD, PhD
• Questions
• Lunch
• Intraoperative Consultations in GI Pathology — Stuti Shroff, MBBS, PhD
• Endocrine Tumors of the Tubal Gut — Michael G. Drage, MD, PhD
• Questions
• Break
• Cytology and Small Biopsy Diagnosis of Pancreatic Neoplasms — Hannah H. Chen, MBCHB, PhD
• Slide Seminar: Instructive Cases in Pancreatic Pathology — Esther Baranov, MD
• Gallbladder and Biliary Tract Pathology — Miranda Machacek, MD, PhD
• Questions
• Approach to Chronic Hepatitis — Angela Shih, MD
• Drug-related Liver Injury — Lei Zhao, MD, PhD
• Clinician’s Perspective on Liver Biopsies — Daniel S. Pratt, MD
• Questions
• Break
• Updates in Primary Hepatic Neoplasms — Lei Zhao, MD, PhD
• Granulomatous Disease in the Liver — Angela Shih, MD
• Case Seminar: Challenging Liver Cases — Hannah H. Chen, MBCHB, PhD
• Conclusion and Farewell

Learning Objectives

Upon completion of this activity, participants will be able to:

• Discuss updates in the new WHO classification of tumors of the digestive system.
• Identify newly described entities in the differential diagnosis of inflammatory disorders of the GI tract.
• Evaluate morphological criteria and role of ancillary techniques (immunohistochemistry and molecular methods) in diagnosis of pre-neoplastic lesions of the GI tract.
• Use screening methods for heritable cancers and standard of care biomarkers currently used for targeted therapy.
• Recognize nuances of interpretation of morphological patterns in liver biopsy interpretation and how to integrate them with clinical findings to render a final diagnosis.
• Recognize proper application and limitations of disease staging and grading systems.
• Recognize common and uncommon hepatic tumors.
• Recognize nuances of interpretation of morphological patterns in pancreatic biopsy interpretation and how to integrate them with clinical findings to render a final diagnosis.
• Describe the spectrum of benign and neoplastic pancreatic disorders with emphasis on use of proper nomenclature and reporting findings of prognostic significance.

Speakers

This program features a distinguished faculty of experts in gastrointestinal, liver, and pancreatic pathology who share clinical insights and diagnostic expertise through comprehensive lectures and case discussions.

• Mark Redston, MD
• Kunal Jajoo, MD
• Jonathan N. Glickman, MD, PhD
• Stuti Shroff, MBBS, PhD
• Jeffrey Goldsmith, MD
• Miranda Machacek, MD, PhD
• Michael G. Drage, MD, PhD
• Mari Mino-Kenudson, MD
• Jason L. Hornick, MD, PhD
• David Papke, MD, PhD
• Judith A. Ferry, MD
• Jonathan Nowak, MD, PhD
• Hannah H. Chen, MBCHB, PhD
• Esther Baranov, MD
• Angela Shih, MD
• Lei Zhao, MD, PhD
• Daniel S. Pratt, MD

Target Audience

• Nurse Practitioners
• Specialty Physicians
• Pathology Assistants

Why This Topic Matters

Harvard Gastrointestinal, Liver, and Pancreatic Pathology 2025 addresses critical diagnostic challenges and updates in gastrointestinal, liver, and pancreatic pathology, essential for specialists involved in these fields. As pathology classifications and diagnostic modalities evolve, this resource reinforces professional knowledge and confidence in applying current standards effectively.

For pathologists and related healthcare professionals, this course provides a valuable platform through MedHub Central to advance understanding of disease morphology, ancillary testing, and reporting practices, supporting precise patient diagnosis and management in gastrointestinal pathology specialties.